An odyssey into biologic therapy
Wujcik, D.
Oncology Nursing Forum 20(6): 879-887
1993
ISSN/ISBN: 0190-535X PMID: 8367342 Document Number: 413885
Document emailed within 1 workday
Related Documents
Tutrone, W.D.; Kagen, M.H.; Barbagallo, J.; Weinberg, J.M. 2001: Biologic therapy for psoriasis: a brief history, i Cutis 68(5): 331-336Brown, T.D. 1989: Biologic response modifiers: understanding biologic systems Texas Medicine 85(11): 4-5
Brown, T.D. 1989: Biologic response modifiers: understanding biologic systems Texas Medicine 85(11): 4-5
Fleischmann, R.M. 2002: Examining the efficacy of biologic therapy: are there real differences? Journal of Rheumatology. Supplement 65: 27-32
Quesada, J.R. 1989: Biologic response modifiers in cancer therapy: a review Texas Medicine 85(11): 42-47
Ortleb, M.; Levitt, J.O. 2012: Practical use of biologic therapy in dermatology: some considerations and checklists Dermatology Online Journal 18(2): 2
Bhave, M.; Akhter, N.; Rosen, S.T. 2014: Cardiovascular toxicity of biologic agents for cancer therapy Oncology 28(6): 482-490
Penn, C.L. 2007: A medical odyssey Journal of the Arkansas Medical Society 104(2): 30-33
Holcenberg, J.S. 1970: Drug therapy. 8. Clinical application of the biologic half-life of drugs Northwest Medicine 69(11): 857-859
Cawello, W.; Bonn, R. 1983: The effect on biologic availability of the choice of infusion material in nitroglycerin therapy Arzneimittel-Forschung 33(4): 595-597
Quesada, J.R. 1988: Biologic response modifiers in the therapy of metastatic renal cell carcinoma Seminars in Oncology 15(4): 396-407
Weinberg, J.M.; Saini, R.; Tutrone, W.D. 2002: Biologic therapy for psoriasis--the first wave: infliximab, etanercept, efalizumab, and alefacept Journal of Drugs in Dermatology: Jdd 1(3): 303-310
Clutterbuck, D. 1984: 2001: a nursing odyssey? Nursing Times 80(17): Suppl 3
Feuchtenberger, M.; Kleinert, S.; Scharbatke, E.-C.; Gnann, H.; Behrens, F.; Wittig, B.M.; Greger, G.; Tony, H.-P. 2015: The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 33(3): 321-329
Weinberg, J.M.; Saini, R. 2003: Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept Cutis 71(1): 25-29
Bissonnette, R.; Kerdel, F.; Naldi, L.; Papp, K.; Galindo, C.; Langholff, W.; Tang, K.L.; Szapary, P.; Fakharzadeh, S.; Srivastava, B.; Goyal, K.; Gottlieb, A.B. 2017: Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis Journal of Drugs in Dermatology: Jdd 16(10): 1002-1013
Skroza, N.; Proietti, I.; Bernardini, N.; La Viola, G.; Nicolucci, F.; Tolino, E.; Zuber, S.; Potenza, C. 2012: Severe psoriasis with positive tuberculosis test and treatment with biologic therapy: a case report Cutis 90(3): 120-122
Mandel, I.D.; Updike, J. 1995: John Updike's dental odyssey Journal of the History of Dentistry 43(2): 51-53
Andrews Reynolds, E. 1977: Realities of an Odyssey in Correctional Education Offender Rehabilitation 1(4): 373-380
Aviss, A. 1984: 2001: a nursing odyssey. Renaissance in the regions Nursing Times 80(17): Suppl: 7-8